Serum sPECAM-1 and sVCAM-1 levels are associated with conversion to multiple sclerosis in patients with optic neuritis

J Neuroimmunol. 2016 Nov 15:300:11-14. doi: 10.1016/j.jneuroim.2016.10.003. Epub 2016 Oct 6.

Abstract

Platelet-Endothelial-Cell-Adhesion-Molecule-1 (PECAM-1) and Human-Vascular-CAM-1 (VCAM-1) are adhesion molecules involved in leukocyte-endothelial interaction. In our study serum levels of sPECAM-1 and sVCAM-1 were measured (ELISA) in twenty-nine patients during their first monosymptomatic optic neuritis (ON) episode. Anti-aquaporin-4-antibodies (AQP4-IgG) were detected with the cell-based assay. Patients were followed for seven years, during which 16/24 AQP4-IgG (-) patients developed MS and 2/5 AQP4-IgG (+) patients developed NMO. Patients who developed MS had significantly lower sPECAM-1 and sVCAM-1 than those who did not. Serum sPECAM-1 and sVCAM-1 may turn out to be useful biomarkers correlated with the risk of progression to MS after first ON incident.

Keywords: Biomarkers; Human Vascular Cell Adhesion Molecule-1 (VCAM-1); Multiple sclerosis; Neuromyelitis optica; Optic neuritis; Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1).

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Biomarkers / blood
  • Cohort Studies
  • Disease Progression*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Multiple Sclerosis / blood*
  • Multiple Sclerosis / diagnosis
  • Optic Neuritis / blood*
  • Optic Neuritis / diagnosis
  • Pilot Projects
  • Platelet Endothelial Cell Adhesion Molecule-1 / blood*
  • Retrospective Studies
  • Vascular Cell Adhesion Molecule-1 / blood*
  • Young Adult

Substances

  • Biomarkers
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Vascular Cell Adhesion Molecule-1